Vulnerability Monitor

The vendors, products, and vulnerabilities you care about

CVE-2020-16218


In Patient Information Center iX (PICiX) Versions B.02, C.02, C.03, the software does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is then used as a webpage and served to other users. Successful exploitation could lead to unauthorized access to patient data via a read-only web application.


Security Impact Summary

This vulnerability carries a LOW severity rating with a CVSS v3.1 score of 3.5, indicating it requires adjacent network access with relatively low complexity without requiring user interaction requiring only low-level privileges . The vulnerability impacts limited data confidentiality, for affected systems. Impacting 1 product from philips organizations running these solutions should prioritize assessment and patching.

Historical Context

Reported in 2020, this vulnerability emerged during an era marked by increased sophistication in supply chain attacks, cloud infrastructure vulnerabilities, and software-as-a-service (SaaS) security challenges. Security practices during this period emphasized zero-trust architectures, container security, and API protection.


Published

2020-09-11T13:15:11.237

Last Modified

2026-02-23T18:20:57.540

Status

Modified

Source

[email protected]

Severity

CVSSv3.1: 3.5 (LOW)

CVSSv2 Vector

AV:A/AC:L/Au:S/C:P/I:N/A:N

  • Access Vector: ADJACENT_NETWORK
  • Access Complexity: LOW
  • Authentication: SINGLE
  • Confidentiality Impact: PARTIAL
  • Integrity Impact: NONE
  • Availability Impact: NONE
Exploitability Score

5.1

Impact Score

2.9

Weaknesses
  • Type: Secondary
    CWE-79

Affected Vendors & Products
Type Vendor Product Version/Range Vulnerable?
Application philips patient_information_center_ix b.02 Yes
Application philips patient_information_center_ix c.02 Yes
Application philips patient_information_center_ix c.03 Yes

References

How SecUtils Interprets This CVE

SecUtils normalizes and enriches National Vulnerability Database (NVD) records by standardizing vendor and product identifiers, aggregating vulnerability metadata from both NVD and MITRE sources, and providing structured context for security teams. For philips's affected products, we extract Common Platform Enumeration (CPE) data, Common Weakness Enumeration (CWE) classifications, CVSS severity metrics, and reference data to enable rapid vulnerability prioritization and asset correlation. This record contains no exploit code, proof-of-concept instructions, or attack methodologies—only defensive intelligence necessary for patch management, risk assessment, and security operations.